Mar 23, 2021

New Guidance for Clinical Trial Participation by Cancer Patients Receiving a COVID-19 Vaccination

An international group of cancer clinical research experts reported new recommendations that receiving a COVID-19 vaccination should not preclude a cancer patient from participating on a clinical trial. Huntsman Cancer Institute physician-scientist and professor of internal medicine at the University of Utah, Neeraj Agarwal, MD, was part of this newly formed group who reviewed the data and provided recommendations to patients, doctors, research centers, and the pharmaceutical research industry on this critical, emerging issue.

Mar 03, 2021

Utah Researchers Illuminate Potential Precursors of Blood Cancers

Utah researchers report significant new insights into the development of blood cancers. Comparing DNA data in people with and without blood disorders, the researchers discovered genetic mutations in about 2% of the presumably healthy participants that were identical to those frequently observed in the cancer patients. These findings provide new clues about mutations that may initiate cancer development and those that may help cancer progress.

Mar 02, 2021

Huntsman Cancer Institute Urges all Adults to Take Action and Schedule Health and Cancer Screenings

Huntsman Cancer Institute experts are urging people to make sure they are up to date on their cancer screenings. This message follows national trends indicating far fewer cancers diagnosed in recent months as compared to prior years. Doctors are alarmed, as there is no evidence to suggest fewer cases of cancers; rather, it is believed that cancer diagnoses are down as many individuals or organizations canceled or postponed health appointments, including cancer screenings, during the COVID-19 pandemic.

Feb 05, 2021

Sachin Apte Joins Huntsman Cancer Institute as Chief Clinical Officer

Huntsman Cancer Institute and University of Utah Health welcome Sachin Apte, MD, MS, MBA. Apte was recruited from Moffitt Cancer Center and will serve as chief clinical officer of HCI and physician-in-chief of the cancer hospital. Selected following an extensive national search, Apte begins his appointment on February 8, 2021.

Jan 28, 2021

Huntsman Cancer Institute Joins Leading Cancer Organizations to Warn Cancer Doesn’t Stop for COVID-19 and Neither Should You

Huntsman Cancer Institute is teaming up with the National Comprehensive Cancer Network®, the American Cancer Society, and other leading organizations across the country to endorse resuming cancer screening and treatment during the ongoing COVID-19 pandemic. The coalition released a letter stating that cancer still poses a major threat to people’s health.

Jan 20, 2021

American Society of Hematology Selects Ami Patel to Receive a 2021 ASH Scholar Award

HCI physician-scientist Ami Patel, MD, has been selected by the American Society of Hematology (ASH) to receive a Scholar Award for her research in leukemia. ASH Scholar Awards are one of ASH’s most prestigious research award programs. They provide financial support to fellows and junior faculty who have dedicated their careers to advancing the field of hematology research as they transition from training programs to careers as independent investigators.

Jan 13, 2021

Systemic Racism is a Public Health Crisis

Huntsman Cancer Institute joins Utah’s health care systems/hospital to address the public health crisis of racism. As members and leaders from Utah’s health care organizations, we believe systemic racism is a real threat to the health of our patients, our families, and our communities. Systemic racism includes a complex array of economic and resource inequalities found throughout significant parts of the U.S. society. Domestic tranquility, for everyone, is an achievable goal.

Jan 07, 2021

V Foundation Awards Two Huntsman Cancer Institute Researchers

Two researchers at Huntsman Cancer Institute at the University of Utah received awards from the V Foundation for Cancer Research. Charles R. Rogers was awarded the 2020 V Scholar Grant, which funds high-impact projects led by faculty who are early in their careers. Jennifer Doherty received the 2020 Robin Roberts Cancer Thrivership Research Award, which supports research areas related to survivorship.